+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 96 Pages
  • September 2020
  • Region: Global
  • GlobalData
  • ID: 5145959
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Ablation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Ablation Devices Overview
3 Products under Development
3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development
3.2 Cardiac Ablation Devices - Pipeline Products by Territory
3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path
3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
3.5 Cardiac Ablation Devices - Ongoing Clinical Trials
4 Cardiac Ablation Devices - Pipeline Products under Development by Companies
4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development
5 Cardiac Ablation Devices Companies and Product Overview
5.1 AblaCor Medical Corporation Company Overview
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adagio Medical Inc. Company Overview
5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 AFreeze GmbH Company Overview
5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.4 AngioDynamics Inc Company Overview
5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Atrian Medical Ltd Company Overview
5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 AtriCure Inc Company Overview
5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Baylis Medical Company Inc Company Overview
5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Corfigo Inc Company Overview
5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Coridea, LLC Company Overview
5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 CPSI Biotech Company Overview
5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.11 Ethicon US LLC Company Overview
5.11.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Helical Solutions, Inc. (Inactive) Company Overview
5.12.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.13 Imricor Medical Systems Inc Company Overview
5.13.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Johns Hopkins University Company Overview
5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kardium Inc Company Overview
5.15.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 LuxCath, LLC Company Overview
5.16.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Medtronic Plc Company Overview
5.17.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Northwestern University Company Overview
5.18.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.19 Sheba Medical Center Company Overview
5.19.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.20 Spectranetics Corp Company Overview
5.20.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 Thermedical Inc Company Overview
5.21.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Tufts Medical Center Company Overview
5.22.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of California Los Angeles Company Overview
5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.24 University of Chicago Company Overview
5.24.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.25 VytronUS Inc Company Overview
5.25.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Cardiac Ablation Devices- Recent Developments7 Appendix
List of Tables
Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 8: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AutoBlator - Product Status
Table 10: AutoBlator - Product Description
Table 11: CircumBlator AF Catheter Ablation System - Product Status
Table 12: CircumBlator AF Catheter Ablation System - Product Description
Table 13: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: iCLAS System - Product Status
Table 15: iCLAS System - Product Description
Table 16: Adagio Medical Inc. - Ongoing Clinical Trials Overview
Table 17: iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
Table 18: iCLAS System - iCLAS for Persistent Atrial Fibrillation
Table 19: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 20: CoolLoop - Product Status
Table 21: CoolLoop - Product Description
Table 22: Tip-Catheter - Product Status
Table 23: Tip-Catheter - Product Description
Table 24: AFreeze GmbH - Ongoing Clinical Trials Overview
Table 25: CoolLoop - Treatment Success with the CoolLoop Cryoablation System - Post-Market Surveillance
Table 26: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Non-Thermal Vein Ablation Device - Product Status
Table 28: Non-Thermal Vein Ablation Device - Product Description
Table 29: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: mPEF Device - Atrial Fibrillation - Product Status
Table 31: mPEF Device - Atrial Fibrillation - Product Description
Table 32: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: AtriCure Bipolar System - Product Status
Table 34: AtriCure Bipolar System - Product Description
Table 35: Isolator Synergy Encompass Clamp - Product Status
Table 36: Isolator Synergy Encompass Clamp - Product Description
Table 37: AtriCure Inc - Ongoing Clinical Trials Overview
Table 38: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
Table 39: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Cardiac Ablation Mitigating Device - Product Status
List of Figures
Figure 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Figure 2: Cardiac Ablation Devices - Pipeline Products by Territory
Figure 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Figure 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Figure 5: Cardiac Ablation Devices - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AblaCor Medical Corporation
  • Adagio Medical Inc.
  • AFreeze GmbH
  • AngioDynamics Inc
  • Atrian Medical Ltd
  • AtriCure Inc
  • Baylis Medical Company Inc
  • Corfigo Inc
  • Coridea, LLC
  • CPSI Biotech
  • Ethicon US LLC
  • Helical Solutions, Inc. (Inactive)
  • Imricor Medical Systems Inc
  • Johns Hopkins University
  • Kardium Inc
  • LuxCath, LLC
  • Medtronic Plc
  • Northwestern University
  • Sheba Medical Center
  • Spectranetics Corp
  • Thermedical Inc
  • Tufts Medical Center
  • University of California Los Angeles
  • University of Chicago
  • VytronUS Inc